Biomarker, Innovation, Research
October 19, 2018
Via: The Medical NewsSome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs following their approval by the European Medicines Agency (EMA). The average decision time is longer than one […]